As a high-tech enterprise invested by Nanjing CHICO Pharmaceutical Co., Ltd., Anqing CHICO Pharmaceutical Co., Ltd is mainly engaged in the MAH/CDMO service of APIs and production of high-end pharmaceutical intermediates. Since inception, we have devoted ourselves to the research, development and production of small molecule targeted anti-tumor, anti-diabetic, anti-cardiovascular APIs and pharmaceutical intermediates.

         Our company is located in Anqing High-tech Industrial Development Zone (a national chemical park) in Anhui province, covering an area of 20,000㎡, with two three-storey Class A plant buildings including  6 workshops: 2 of them are used for the manufacturing of High-end pharmaceutical intermediates, and the rest 4 workshops are GMP workshop, which are utilized to provide MAH services. 
          We also set an R&D center in  JSLS at No. 9 Weidi Road in Nanjing city, with a total land of 1,800㎡. We have an experienced and energetic R&D team equipped with advanced organic synthesis and analytical testing apparatus. Also we areequipped with the data audit trail system (online version) and ISO9001 quality certificated management system which can help us meet the regulatory requirements for API registration and declaration.